share_log

Intensity Therapeutics, Inc To Start Trading Tomorrow

Intensity Therapeutics, Inc To Start Trading Tomorrow

強度治療公司將於明天開始交易
Benzinga Real-time News ·  2022/10/13 10:04

Intensity Therapeutics, Inc (NASDAQ:INTS) IPO will take place October, 14 on the NASDAQ exchange under the ticker INTS.

強度治療公司(納斯達克股票代碼:INTS)首次公開募股將於10月14日在納斯達克交易所進行,股票代碼為INTS。

The company is offering shares at an expected price between $4.00 and $5.00 per share with an insider lock-up period of 180 days ending on April 12, 2023.

該公司將以每股4.00美元至5.00美元的預期價格發行股票,內部禁售期為180天,至2023年4月12日結束。

See also: Benzinga IPO Calendar

另見: Benzinga IPO日程表

About Intensity Therapeutics, Inc

關於強度治療公司

Intensity Therapeutics, Inc is a clinical-stage biotechnology company whose treatment approach addresses both the regional and systemic nature of a patient's cancer

強度治療公司是一家臨牀階段的生物技術公司,其治療方法針對患者癌症的區域性和全身性

See also: Benzinga's Most Shorted Stocks

另見: Benzinga最賣空的股票

This article was generated by Benzinga's automated content engine and reviewed by an editor.

本文由Benzinga的自動內容引擎生成,並由編輯審閲。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論